Digital Frontiers Health 2022 - day 2 And the LIVE coverage continues as we head into Day Two... This day is set to hold even more points of interest, with the demonstration ‘CX innovation: building experiences that wo
News Ipsen' Bylvay fluffs its lines in biliary atresia trial Ipsen's IBAT inhibitor Bylvay has failed a trial in biliary atresia, a rare and serious liver disease that affects babies and has limited treatments.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.